Skip to main content
. Author manuscript; available in PMC: 2014 Oct 2.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2013 Jun 27;13(5):568–574. doi: 10.1016/j.clml.2013.03.012

Table 4.

Response in 96 patients treated at the Phase II recommended dose

RS (N=31) Refractory CLL (N= 65)
No. of patients % No. of patients %
  CR 2 6.5 3 4.6
nPR 0 0 9 13.9
  PR 10 32.2 21 32.3
  Overall response 12 38.7 33 50.8

Abbreviations: CLL= chronic lymphocytic leukemia; CR = complete response; nPR = nodular partial response; PR = partial response; RS = Richter syndrome